Article
Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Dec 2003
Miyoshi Yasuo, Noguchi Shinzaburo
Abstract excerpt
Recent success of chemoprevention with tamoxifen has opened a new era wherein prevention of breast cancer is much more emphasized than treatment of established breast cancer. Since tamoxifen has been shown to reduce the risk of estrogen receptor (ER)-positive, but not ER-negative, breast cancer in the chemoprevention trial (P-1), it seems to be important to develop risk factors for ER-positive breast cancer in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
